Mechthild Krause, Prof.

ESMO-ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors The combination of radiotherapy (RT) with targeted agents or immunotherapy may result in improved outcomes, but it can also increase toxicity. However…

Read the paper on radiotherapy with immun checkpoint and TK inhibitors - ESTRO/ESMO consensus about risks of combination
www.sciencedirect.com/science/arti...

#WissenschaftlicheIntegritaet: Die Leitlinie 14 des Kodex beschäftigt sich mit der #Autorschaft: Wann gilt man als Autor*in einer Arbeit? Was ist ein genuiner Beitrag? Was muss bei einer Publikation mit Blick auf die #GWP beachtet werden? 1/3

Progressive Voices Award 2025 - Brand New Bundestag Bereits das dritte Jahr in Folge lenken wir den Blick bewusst auf das Mutmachende in Politik und Gesellschaft und verleihen den Progressive Voices Award 2025.

Wissenschaft für Demokratie – Wir für Dich e.V. – ist für den Progressive Voices Award 2025 nominiert worden! 🎉. Stimmt ab, Ihr habt 5 Stimmen, auch in den anderen Kategorien für tolle Initiativen

Abstimmung: brandnewbundestag.de/progressive-...

Teilen ausdrücklich erwünscht! 💜

Aus der Praxis des Kulturbüro Sachsen: Halsbrücke. Wie sich Berger*innen gegen die Ansiedlung von Reichsbürger*innen wehren können. Motiv: Brücke in Halsbrücke

💪 Selbstwirksam aktiv gegen #RechteRaumnahme durch #Reichsbürger !

Unser Beratungsfall aus #Halsbrücke #Sachsen ist ein schönes Beispiel dafür, wie zivilgesellschaftliches Engagement gg #Rechtsextremismus in langfristiges, konstruktives Engagement für #Demokratie münden kann.

Cell-specific analysis of microglia following partial brain proton irradiation in mice In recent years, proton therapy has been established as a curative treatment for pediatric brain tumors and has demonstrated significant potential for adult brain tumors [1,2]. The advantage of proton...

After brain irradiation, microglia density increases with dose, more in the periventricular region. Correlation with contrast enhancementin MRI -- potential mechanism of brain necrosis. #RadOnc @hzdr.bsky.social @oncoalert.bsky.social

www.ctro.science/article/S240...

Zum ersten Mal hybrid Fortbildung für Patientenvertreter und Interessierte auf dem #DEGRO Kongress. Danke den ca 80 Teilnehmer:innen, davon 40 vor Ort. Und den Mitorganisatoren. @dkfz.bsky.social

Danke an die co-Kongresspräsidentinnen Esther Troost und Andrea Wittig und die Kongress- Koordinatorin Katja Storch #DEGRO

Der #DEGRO Kongress geht heute zuende. Sehr spannende Sitzung: was können wir eigentlich aus welchen Studien schlussfolgern?

Vienna outside of the conference Center 😊 #ESTRO25

Two of the talks in the best papers session came from Dresden. Congratulations Martina Palkowitsch, PhD student, and Annett Linge, clinician scientist. #ESTRO25 #radonc

I’m SO delighted to finally see first STAR-TREC data reported 🤩 #ESTRO25

Short course RT vs chemorad for organ preservation in early stage rectal cancer

61% vs 80% TME-free survival at 12 months ➡️ More organ preservation with long-course chemorad!
#radonc #rectalcancer

HYPO-RT-PC Phase III trial: Two-Week Radiotherapy Proven as Safe and Effective as Eight-Week Course for Prostate Cancer, After 10-Year Follow-Up - OncoDaily HYPO-RT-PC trial shows that ultra-hypofractionated radiotherapy is as effective and safe as 8-weektx for localized prostate cancer

oncodaily.com/societies/hy...

RFK Jr. Orders Search for New Measles Treatments Instead of Urging Vaccination Decades of research have turned up no miracle treatment for measles, but studies show the M.M.R. shot is 97 percent effective in preventing the disease.

Robert F. Kennedy Jr. will direct federal health agencies to explore potential new treatments for measles as the U.S. faces its largest outbreak in 25 years. Experts fear the decision could have grave consequences, as studies show the existing vaccine is 97% effective in preventing infection.

Congratulations Michael Baumann @dkfz.bsky.social to the Jens Overgaard Legacy Award #ESTRO25 #RadOnc

Try at Boston Scientific. Little queue, good coffee ☕️

This is currently the only plausible reason. We should not ignore that but find out if there are subgroups (what they tried and could not identify)

Birgitte Offersen showing the results of Skagen1 trial - hypofx vs conventional RT in high risk breast cancer patients with indication for lymphnode irradiation. Same side effects, same local control but worse survival. Due to lower RT dose? #ESTRO25 #RadOnk

At Sep 7th 1953 the first patient hast received radiotherapy with a linear accelerator.
Sept 7th, 2025 will be the world radiotherapy awareness day.
Safe and effektive treatment to cure cancer. Equal access worldwide still a problem.

Erstmalig aktive Patientenbeteiligung. Fortbildungsprogramm und aktive Beteiligung in ausgewählten Sitzungen. Selbsthilfegruppen sind vor Ort. Anmeldung notwendig (kostenfrei)
www.degro-kongress.org/rahmenprogra...

DEGRO 2025 – Radioonkologie [Teamwork] Maßgeschneidert. Patientenzentriert. Zukunftsorientiert. Selbstbestimmt im Team Der 31. Kongress der Deutschen Gesellschaft für Radioonkologie findet vom 19. bis 21. Juni 2025 in Dresden statt.

www.degro-kongress.org
DEGRO-Kongress, 19.-21.06.2025 in der Messe Dresden. Hochwertige Wissenschaft + schöne Stadt. Sehr viele haben sich schon angemeldet - Sie auch?
Patienten unten weiterlesen

Congratulations!

Great and much needed trial, looking forward the tumor outcome

A Randomized Study of Consolidation Chemoradiotherapy Versus Observation After First-line Chemotherapy in Advanced Gallbladder Cancers: RACE-GB study Chemotherapy (CT) is the standard of care for patients presenting with unresectable advanced gallbladder carcinoma (GBC) but their prognosis remains poor. The value of consolidation CT and radiation t...

RACE-GB, the first ever phase 3 randomized study showing overall survival improvement from chemotherapy combined with #radiation for gallbladder cancer.
Article: www.redjournal.org/article/S036...
Podcast: www.redjournal.org/audio-do/red...

The New England Journal of Medicine Axillary Surgery in Breast Cancer A Research Summary based on Reimer T et al. | 10.1056/NEJMoa2412063 | Published on December 12, 2024 Visual representations of the patients in the trial and the treatments they were assigned. Read the full Research Summary at NEJM.org.

The INSEMA trial involving patients with clinically node-negative, T1 breast cancer showed that the omission of axillary surgery was noninferior to sentinel-lymph-node biopsy. Full trial results and Research Summary: nej.md/41o5L0Z

#MedSky #Oncology

Boswellia Serrata for Cerebral Radiation Necrosis After Radiosurgery for Brain Metastases Radiation necrosis (RN) is a dose-limiting toxicity of stereotactic radiosurgery (SRS) for brain metastases. Oral corticosteroids are not optimal for long-term management, given multiple side effects....

The bird people seemed very excited about this study.
#IJROBP #radonc
www.redjournal.org/article/S036...

Grafik mit Text: Gemeinsam sind wir stärker. #Zusammenland

Wir unterstützen die Kampagne #Zusammenland für Demokratie, Zusammenhalt, Weltoffenheit und Respekt!

Handwritten notes on a metal table at the National Science Foundation, 2/18/25. The messages include "You deserve better! Thank you!"; "Thank you colleagues! This RIF is WRONG. These orders are immoral & illegal"; and "Your service will forever be remembered and deeply valued - ENG directorate".

This morning, the US National Science Foundation fired 168 employees, approximately 10% of its workforce, for no cause other than they were the agency's most recent hires. 🧪

Co-workers are leaving supportive messages before they have to clear out of the building at 5 p.m. Sent to me by a source ⬇️

Research Associate in Biomaterials:University campus and The Christie NHS Foundation Trust site, Withington, Manchester

👀 Take a look - we're on the hunt for a #postdoc to join us. Interested in innovative 3D models for translational research? @official-uom.bsky.social @mcrcnews.bsky.social @profajchalmers.bsky.social
www.jobs.manchester.ac.uk/internal/Job...